nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0783	0.104	CbGbCtD
Linagliptin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0593	0.0787	CbGbCtD
Linagliptin—ABCB1—Betamethasone—systemic lupus erythematosus	0.0509	0.0676	CbGbCtD
Linagliptin—ABCB1—Prednisolone—systemic lupus erythematosus	0.0502	0.0667	CbGbCtD
Linagliptin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0476	0.0632	CbGbCtD
Linagliptin—ABCB1—Prednisone—systemic lupus erythematosus	0.0474	0.063	CbGbCtD
Linagliptin—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0469	0.0623	CbGbCtD
Linagliptin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.045	0.0597	CbGbCtD
Linagliptin—CYP3A4—Dapsone—systemic lupus erythematosus	0.041	0.0544	CbGbCtD
Linagliptin—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0356	0.0472	CbGbCtD
Linagliptin—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0356	0.0472	CbGbCtD
Linagliptin—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0305	0.0405	CbGbCtD
Linagliptin—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0301	0.0399	CbGbCtD
Linagliptin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0296	0.0393	CbGbCtD
Linagliptin—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0285	0.0379	CbGbCtD
Linagliptin—CYP3A4—Prednisone—systemic lupus erythematosus	0.0284	0.0377	CbGbCtD
Linagliptin—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0269	0.0358	CbGbCtD
Linagliptin—ABCB1—Methotrexate—systemic lupus erythematosus	0.0238	0.0316	CbGbCtD
Linagliptin—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0177	0.0235	CbGbCtD
Linagliptin—DPP4—blood plasma—systemic lupus erythematosus	0.00657	0.139	CbGeAlD
Linagliptin—CYP3A4—urine—systemic lupus erythematosus	0.00411	0.087	CbGeAlD
Linagliptin—DPP4—connective tissue—systemic lupus erythematosus	0.0035	0.0741	CbGeAlD
Linagliptin—DPP4—nephron tubule—systemic lupus erythematosus	0.00339	0.0718	CbGeAlD
Linagliptin—DPP4—kidney—systemic lupus erythematosus	0.00298	0.0631	CbGeAlD
Linagliptin—DPP4—cortex of kidney—systemic lupus erythematosus	0.0029	0.0615	CbGeAlD
Linagliptin—DPP4—lymphoid tissue—systemic lupus erythematosus	0.00256	0.0542	CbGeAlD
Linagliptin—DPP4—tendon—systemic lupus erythematosus	0.00241	0.0509	CbGeAlD
Linagliptin—DPP4—bone marrow—systemic lupus erythematosus	0.00233	0.0493	CbGeAlD
Linagliptin—CYP3A4—blood plasma—systemic lupus erythematosus	0.00214	0.0454	CbGeAlD
Linagliptin—DPP4—lung—systemic lupus erythematosus	0.00211	0.0447	CbGeAlD
Linagliptin—Hyperlipidaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00206	0.0104	CcSEcCtD
Linagliptin—DPP4—nervous system—systemic lupus erythematosus	0.00196	0.0414	CbGeAlD
Linagliptin—DPP4—central nervous system—systemic lupus erythematosus	0.00188	0.0399	CbGeAlD
Linagliptin—Hypertriglyceridaemia—Prednisone—systemic lupus erythematosus	0.00175	0.00881	CcSEcCtD
Linagliptin—Diabetes mellitus—Leflunomide—systemic lupus erythematosus	0.00165	0.00828	CcSEcCtD
Linagliptin—Blood triglycerides increased—Prednisone—systemic lupus erythematosus	0.00154	0.00772	CcSEcCtD
Linagliptin—ABCB1—blood plasma—systemic lupus erythematosus	0.00152	0.0321	CbGeAlD
Linagliptin—Cough—Dapsone—systemic lupus erythematosus	0.00141	0.00708	CcSEcCtD
Linagliptin—Skin exfoliation—Hydrocortisone—systemic lupus erythematosus	0.00129	0.00649	CcSEcCtD
Linagliptin—Pancreatitis—Azathioprine—systemic lupus erythematosus	0.00129	0.00646	CcSEcCtD
Linagliptin—Diabetes mellitus—Cyclosporine—systemic lupus erythematosus	0.00127	0.00639	CcSEcCtD
Linagliptin—Diabetes mellitus—Mycophenolate mofetil—systemic lupus erythematosus	0.00124	0.00623	CcSEcCtD
Linagliptin—Skin exfoliation—Triamcinolone—systemic lupus erythematosus	0.00122	0.00611	CcSEcCtD
Linagliptin—Skin exfoliation—Methylprednisolone—systemic lupus erythematosus	0.00121	0.0061	CcSEcCtD
Linagliptin—Pancreatitis—Leflunomide—systemic lupus erythematosus	0.00121	0.0061	CcSEcCtD
Linagliptin—Infestation NOS—Azathioprine—systemic lupus erythematosus	0.00117	0.00587	CcSEcCtD
Linagliptin—Infestation—Azathioprine—systemic lupus erythematosus	0.00117	0.00587	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisolone—systemic lupus erythematosus	0.00116	0.00581	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Leflunomide—systemic lupus erythematosus	0.00115	0.00578	CcSEcCtD
Linagliptin—Hypoglycaemia—Cyclosporine—systemic lupus erythematosus	0.00113	0.00569	CcSEcCtD
Linagliptin—Diabetes mellitus—Hydrocortisone—systemic lupus erythematosus	0.00113	0.00568	CcSEcCtD
Linagliptin—Hypoglycaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00111	0.00555	CcSEcCtD
Linagliptin—Skin exfoliation—Betamethasone—systemic lupus erythematosus	0.0011	0.00555	CcSEcCtD
Linagliptin—Skin exfoliation—Dexamethasone—systemic lupus erythematosus	0.0011	0.00555	CcSEcCtD
Linagliptin—Infestation NOS—Leflunomide—systemic lupus erythematosus	0.0011	0.00555	CcSEcCtD
Linagliptin—Infestation—Leflunomide—systemic lupus erythematosus	0.0011	0.00555	CcSEcCtD
Linagliptin—Urinary tract infection—Leflunomide—systemic lupus erythematosus	0.00107	0.00539	CcSEcCtD
Linagliptin—Diabetes mellitus—Triamcinolone—systemic lupus erythematosus	0.00106	0.00534	CcSEcCtD
Linagliptin—Diabetes mellitus—Methylprednisolone—systemic lupus erythematosus	0.00106	0.00533	CcSEcCtD
Linagliptin—CYP3A4—kidney—systemic lupus erythematosus	0.000972	0.0206	CbGeAlD
Linagliptin—Diabetes mellitus—Betamethasone—systemic lupus erythematosus	0.000966	0.00485	CcSEcCtD
Linagliptin—Diabetes mellitus—Dexamethasone—systemic lupus erythematosus	0.000966	0.00485	CcSEcCtD
Linagliptin—Skin exfoliation—Prednisone—systemic lupus erythematosus	0.000962	0.00483	CcSEcCtD
Linagliptin—Immune system disorder—Azathioprine—systemic lupus erythematosus	0.000948	0.00476	CcSEcCtD
Linagliptin—Mediastinal disorder—Azathioprine—systemic lupus erythematosus	0.000946	0.00475	CcSEcCtD
Linagliptin—Pancreatitis—Cyclosporine—systemic lupus erythematosus	0.000937	0.00471	CcSEcCtD
Linagliptin—Pancreatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000914	0.00459	CcSEcCtD
Linagliptin—Immune system disorder—Leflunomide—systemic lupus erythematosus	0.000896	0.0045	CcSEcCtD
Linagliptin—Mediastinal disorder—Leflunomide—systemic lupus erythematosus	0.000894	0.00449	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Cyclosporine—systemic lupus erythematosus	0.000889	0.00446	CcSEcCtD
Linagliptin—Weight increased—Cyclosporine—systemic lupus erythematosus	0.00087	0.00437	CcSEcCtD
Linagliptin—Malnutrition—Leflunomide—systemic lupus erythematosus	0.000863	0.00433	CcSEcCtD
Linagliptin—Pancreatitis—Prednisolone—systemic lupus erythematosus	0.000853	0.00428	CcSEcCtD
Linagliptin—Infestation NOS—Cyclosporine—systemic lupus erythematosus	0.000853	0.00428	CcSEcCtD
Linagliptin—Infestation—Cyclosporine—systemic lupus erythematosus	0.000853	0.00428	CcSEcCtD
Linagliptin—Weight increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000849	0.00426	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisone—systemic lupus erythematosus	0.000841	0.00422	CcSEcCtD
Linagliptin—Back pain—Leflunomide—systemic lupus erythematosus	0.000835	0.00419	CcSEcCtD
Linagliptin—Pancreatitis—Hydrocortisone—systemic lupus erythematosus	0.000833	0.00418	CcSEcCtD
Linagliptin—Infestation NOS—Mycophenolate mofetil—systemic lupus erythematosus	0.000832	0.00418	CcSEcCtD
Linagliptin—Infestation—Mycophenolate mofetil—systemic lupus erythematosus	0.000832	0.00418	CcSEcCtD
Linagliptin—Urinary tract infection—Cyclosporine—systemic lupus erythematosus	0.000829	0.00416	CcSEcCtD
Linagliptin—Headache—Dapsone—systemic lupus erythematosus	0.000827	0.00415	CcSEcCtD
Linagliptin—Urinary tract infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000808	0.00406	CcSEcCtD
Linagliptin—Skin exfoliation—Methotrexate—systemic lupus erythematosus	0.000804	0.00404	CcSEcCtD
Linagliptin—Weight increased—Prednisolone—systemic lupus erythematosus	0.000792	0.00398	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Hydrocortisone—systemic lupus erythematosus	0.00079	0.00397	CcSEcCtD
Linagliptin—Angioedema—Leflunomide—systemic lupus erythematosus	0.000789	0.00396	CcSEcCtD
Linagliptin—Pancreatitis—Triamcinolone—systemic lupus erythematosus	0.000784	0.00394	CcSEcCtD
Linagliptin—Pancreatitis—Methylprednisolone—systemic lupus erythematosus	0.000783	0.00393	CcSEcCtD
Linagliptin—ABCB1—nephron tubule—systemic lupus erythematosus	0.000783	0.0166	CbGeAlD
Linagliptin—Arthralgia—Azathioprine—systemic lupus erythematosus	0.000778	0.00391	CcSEcCtD
Linagliptin—Myalgia—Azathioprine—systemic lupus erythematosus	0.000778	0.00391	CcSEcCtD
Linagliptin—Weight increased—Hydrocortisone—systemic lupus erythematosus	0.000773	0.00388	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000773	0.00388	CcSEcCtD
Linagliptin—Infestation NOS—Hydrocortisone—systemic lupus erythematosus	0.000758	0.0038	CcSEcCtD
Linagliptin—Infestation—Hydrocortisone—systemic lupus erythematosus	0.000758	0.0038	CcSEcCtD
Linagliptin—Cough—Leflunomide—systemic lupus erythematosus	0.000753	0.00378	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Triamcinolone—systemic lupus erythematosus	0.000744	0.00373	CcSEcCtD
Linagliptin—Infection—Azathioprine—systemic lupus erythematosus	0.000741	0.00372	CcSEcCtD
Linagliptin—Myalgia—Leflunomide—systemic lupus erythematosus	0.000735	0.00369	CcSEcCtD
Linagliptin—Arthralgia—Leflunomide—systemic lupus erythematosus	0.000735	0.00369	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00073	0.00367	CcSEcCtD
Linagliptin—Weight increased—Triamcinolone—systemic lupus erythematosus	0.000728	0.00366	CcSEcCtD
Linagliptin—Weight increased—Methylprednisolone—systemic lupus erythematosus	0.000727	0.00365	CcSEcCtD
Linagliptin—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000725	0.00364	CcSEcCtD
Linagliptin—Infestation NOS—Methylprednisolone—systemic lupus erythematosus	0.000712	0.00357	CcSEcCtD
Linagliptin—Infestation—Methylprednisolone—systemic lupus erythematosus	0.000712	0.00357	CcSEcCtD
Linagliptin—Anaphylactic shock—Leflunomide—systemic lupus erythematosus	0.000705	0.00354	CcSEcCtD
Linagliptin—Diabetes mellitus—Methotrexate—systemic lupus erythematosus	0.000703	0.00353	CcSEcCtD
Linagliptin—Infection—Leflunomide—systemic lupus erythematosus	0.0007	0.00351	CcSEcCtD
Linagliptin—Mediastinal disorder—Cyclosporine—systemic lupus erythematosus	0.00069	0.00346	CcSEcCtD
Linagliptin—ABCB1—kidney—systemic lupus erythematosus	0.000688	0.0146	CbGeAlD
Linagliptin—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000684	0.00344	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.00068	0.00341	CcSEcCtD
Linagliptin—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000673	0.00338	CcSEcCtD
Linagliptin—ABCB1—cortex of kidney—systemic lupus erythematosus	0.00067	0.0142	CbGeAlD
Linagliptin—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.000666	0.00335	CcSEcCtD
Linagliptin—Weight increased—Dexamethasone—systemic lupus erythematosus	0.000661	0.00332	CcSEcCtD
Linagliptin—Weight increased—Betamethasone—systemic lupus erythematosus	0.000661	0.00332	CcSEcCtD
Linagliptin—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.00065	0.00326	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000644	0.00323	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000642	0.00322	CcSEcCtD
Linagliptin—CYP3A4—nervous system—systemic lupus erythematosus	0.000638	0.0135	CbGeAlD
Linagliptin—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000629	0.00316	CcSEcCtD
Linagliptin—Pancreatitis—Prednisone—systemic lupus erythematosus	0.00062	0.00311	CcSEcCtD
Linagliptin—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.000614	0.00309	CcSEcCtD
Linagliptin—CYP3A4—central nervous system—systemic lupus erythematosus	0.000614	0.013	CbGeAlD
Linagliptin—Angioedema—Cyclosporine—systemic lupus erythematosus	0.000609	0.00306	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000608	0.00305	CcSEcCtD
Linagliptin—Constipation—Leflunomide—systemic lupus erythematosus	0.000602	0.00303	CcSEcCtD
Linagliptin—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000594	0.00298	CcSEcCtD
Linagliptin—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000592	0.00297	CcSEcCtD
Linagliptin—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000591	0.0125	CbGeAlD
Linagliptin—Cough—Cyclosporine—systemic lupus erythematosus	0.000581	0.00292	CcSEcCtD
Linagliptin—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.000577	0.0029	CcSEcCtD
Linagliptin—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.000576	0.00289	CcSEcCtD
Linagliptin—Weight increased—Prednisone—systemic lupus erythematosus	0.000575	0.00289	CcSEcCtD
Linagliptin—Myalgia—Cyclosporine—systemic lupus erythematosus	0.000567	0.00285	CcSEcCtD
Linagliptin—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000567	0.00285	CcSEcCtD
Linagliptin—Cough—Mycophenolate mofetil—systemic lupus erythematosus	0.000567	0.00285	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000563	0.00283	CcSEcCtD
Linagliptin—Urticaria—Leflunomide—systemic lupus erythematosus	0.00056	0.00281	CcSEcCtD
Linagliptin—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000556	0.00279	CcSEcCtD
Linagliptin—Angioedema—Prednisolone—systemic lupus erythematosus	0.000554	0.00278	CcSEcCtD
Linagliptin—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000553	0.00278	CcSEcCtD
Linagliptin—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000553	0.00278	CcSEcCtD
Linagliptin—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.00055	0.00276	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000549	0.00276	CcSEcCtD
Linagliptin—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000544	0.00273	CcSEcCtD
Linagliptin—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000541	0.00272	CcSEcCtD
Linagliptin—Infection—Cyclosporine—systemic lupus erythematosus	0.00054	0.00271	CcSEcCtD
Linagliptin—Back pain—Triamcinolone—systemic lupus erythematosus	0.000539	0.00271	CcSEcCtD
Linagliptin—ABCB1—bone marrow—systemic lupus erythematosus	0.000538	0.0114	CbGeAlD
Linagliptin—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.00053	0.00266	CcSEcCtD
Linagliptin—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000528	0.00265	CcSEcCtD
Linagliptin—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000527	0.00265	CcSEcCtD
Linagliptin—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000519	0.00261	CcSEcCtD
Linagliptin—Pancreatitis—Methotrexate—systemic lupus erythematosus	0.000518	0.0026	CcSEcCtD
Linagliptin—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000515	0.00259	CcSEcCtD
Linagliptin—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.00051	0.00256	CcSEcCtD
Linagliptin—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000509	0.00256	CcSEcCtD
Linagliptin—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000508	0.00255	CcSEcCtD
Linagliptin—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000504	0.00253	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000501	0.00251	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000495	0.00249	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000495	0.00248	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000491	0.00247	CcSEcCtD
Linagliptin—ABCB1—lung—systemic lupus erythematosus	0.000487	0.0103	CbGeAlD
Linagliptin—Cough—Triamcinolone—systemic lupus erythematosus	0.000486	0.00244	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000483	0.00243	CcSEcCtD
Linagliptin—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000483	0.00243	CcSEcCtD
Linagliptin—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000482	0.00242	CcSEcCtD
Linagliptin—Infection—Hydrocortisone—systemic lupus erythematosus	0.00048	0.00241	CcSEcCtD
Linagliptin—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000475	0.00238	CcSEcCtD
Linagliptin—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000474	0.00238	CcSEcCtD
Linagliptin—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000474	0.00238	CcSEcCtD
Linagliptin—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000471	0.00237	CcSEcCtD
Linagliptin—Infestation—Methotrexate—systemic lupus erythematosus	0.000471	0.00237	CcSEcCtD
Linagliptin—Rash—Azathioprine—systemic lupus erythematosus	0.00047	0.00236	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.00047	0.00236	CcSEcCtD
Linagliptin—Dermatitis—Azathioprine—systemic lupus erythematosus	0.00047	0.00236	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000469	0.00236	CcSEcCtD
Linagliptin—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000469	0.00236	CcSEcCtD
Linagliptin—Headache—Azathioprine—systemic lupus erythematosus	0.000467	0.00235	CcSEcCtD
Linagliptin—Constipation—Cyclosporine—systemic lupus erythematosus	0.000465	0.00233	CcSEcCtD
Linagliptin—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000462	0.00232	CcSEcCtD
Linagliptin—Angioedema—Betamethasone—systemic lupus erythematosus	0.000462	0.00232	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000458	0.0023	CcSEcCtD
Linagliptin—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000457	0.0023	CcSEcCtD
Linagliptin—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000455	0.00228	CcSEcCtD
Linagliptin—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000454	0.00228	CcSEcCtD
Linagliptin—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000454	0.00228	CcSEcCtD
Linagliptin—Infection—Triamcinolone—systemic lupus erythematosus	0.000452	0.00227	CcSEcCtD
Linagliptin—ABCB1—nervous system—systemic lupus erythematosus	0.000451	0.00956	CbGeAlD
Linagliptin—Infection—Methylprednisolone—systemic lupus erythematosus	0.000451	0.00226	CcSEcCtD
Linagliptin—Rash—Leflunomide—systemic lupus erythematosus	0.000444	0.00223	CcSEcCtD
Linagliptin—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000444	0.00223	CcSEcCtD
Linagliptin—Headache—Leflunomide—systemic lupus erythematosus	0.000441	0.00222	CcSEcCtD
Linagliptin—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000441	0.00221	CcSEcCtD
Linagliptin—Malnutrition—Prednisone—systemic lupus erythematosus	0.000441	0.00221	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.00044	0.00221	CcSEcCtD
Linagliptin—ABCB1—central nervous system—systemic lupus erythematosus	0.000435	0.0092	CbGeAlD
Linagliptin—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000432	0.00217	CcSEcCtD
Linagliptin—Myalgia—Betamethasone—systemic lupus erythematosus	0.000431	0.00216	CcSEcCtD
Linagliptin—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000431	0.00216	CcSEcCtD
Linagliptin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000421	0.00212	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000417	0.00209	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000415	0.00208	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000414	0.00208	CcSEcCtD
Linagliptin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000413	0.00207	CcSEcCtD
Linagliptin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000413	0.00207	CcSEcCtD
Linagliptin—Infection—Dexamethasone—systemic lupus erythematosus	0.00041	0.00206	CcSEcCtD
Linagliptin—Infection—Betamethasone—systemic lupus erythematosus	0.00041	0.00206	CcSEcCtD
Linagliptin—Angioedema—Prednisone—systemic lupus erythematosus	0.000403	0.00202	CcSEcCtD
Linagliptin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000401	0.00201	CcSEcCtD
Linagliptin—Urticaria—Prednisolone—systemic lupus erythematosus	0.000393	0.00197	CcSEcCtD
Linagliptin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000391	0.00196	CcSEcCtD
Linagliptin—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000384	0.00193	CcSEcCtD
Linagliptin—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000382	0.00192	CcSEcCtD
Linagliptin—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000381	0.00191	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000376	0.00189	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000376	0.00189	CcSEcCtD
Linagliptin—Myalgia—Prednisone—systemic lupus erythematosus	0.000375	0.00188	CcSEcCtD
Linagliptin—Arthralgia—Prednisone—systemic lupus erythematosus	0.000375	0.00188	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000372	0.00187	CcSEcCtD
Linagliptin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000372	0.00187	CcSEcCtD
Linagliptin—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000368	0.00185	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000365	0.00183	CcSEcCtD
Linagliptin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000363	0.00182	CcSEcCtD
Linagliptin—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000361	0.00182	CcSEcCtD
Linagliptin—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000361	0.00181	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.00036	0.00181	CcSEcCtD
Linagliptin—Infection—Prednisone—systemic lupus erythematosus	0.000357	0.00179	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000356	0.00179	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000356	0.00179	CcSEcCtD
Linagliptin—Back pain—Methotrexate—systemic lupus erythematosus	0.000356	0.00179	CcSEcCtD
Linagliptin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000356	0.00179	CcSEcCtD
Linagliptin—Skin disorder—Prednisone—systemic lupus erythematosus	0.000349	0.00175	CcSEcCtD
Linagliptin—Rash—Cyclosporine—systemic lupus erythematosus	0.000343	0.00172	CcSEcCtD
Linagliptin—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000343	0.00172	CcSEcCtD
Linagliptin—Headache—Cyclosporine—systemic lupus erythematosus	0.000341	0.00171	CcSEcCtD
Linagliptin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000335	0.00168	CcSEcCtD
Linagliptin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000334	0.00168	CcSEcCtD
Linagliptin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000334	0.00168	CcSEcCtD
Linagliptin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000334	0.00168	CcSEcCtD
Linagliptin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000332	0.00167	CcSEcCtD
Linagliptin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000331	0.00166	CcSEcCtD
Linagliptin—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000328	0.00165	CcSEcCtD
Linagliptin—Urticaria—Betamethasone—systemic lupus erythematosus	0.000328	0.00165	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000328	0.00164	CcSEcCtD
Linagliptin—Cough—Methotrexate—systemic lupus erythematosus	0.000321	0.00161	CcSEcCtD
Linagliptin—Myalgia—Methotrexate—systemic lupus erythematosus	0.000313	0.00157	CcSEcCtD
Linagliptin—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000313	0.00157	CcSEcCtD
Linagliptin—Rash—Prednisolone—systemic lupus erythematosus	0.000312	0.00157	CcSEcCtD
Linagliptin—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000312	0.00157	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000311	0.00156	CcSEcCtD
Linagliptin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000311	0.00156	CcSEcCtD
Linagliptin—Headache—Prednisolone—systemic lupus erythematosus	0.00031	0.00156	CcSEcCtD
Linagliptin—Constipation—Prednisone—systemic lupus erythematosus	0.000307	0.00154	CcSEcCtD
Linagliptin—Rash—Hydrocortisone—systemic lupus erythematosus	0.000305	0.00153	CcSEcCtD
Linagliptin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000304	0.00153	CcSEcCtD
Linagliptin—Headache—Hydrocortisone—systemic lupus erythematosus	0.000303	0.00152	CcSEcCtD
Linagliptin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.0003	0.00151	CcSEcCtD
Linagliptin—Infection—Methotrexate—systemic lupus erythematosus	0.000299	0.0015	CcSEcCtD
Linagliptin—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000292	0.00147	CcSEcCtD
Linagliptin—Rash—Triamcinolone—systemic lupus erythematosus	0.000287	0.00144	CcSEcCtD
Linagliptin—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000287	0.00144	CcSEcCtD
Linagliptin—Rash—Methylprednisolone—systemic lupus erythematosus	0.000286	0.00144	CcSEcCtD
Linagliptin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000286	0.00144	CcSEcCtD
Linagliptin—Urticaria—Prednisone—systemic lupus erythematosus	0.000286	0.00143	CcSEcCtD
Linagliptin—Headache—Triamcinolone—systemic lupus erythematosus	0.000285	0.00143	CcSEcCtD
Linagliptin—Headache—Methylprednisolone—systemic lupus erythematosus	0.000284	0.00143	CcSEcCtD
Linagliptin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000282	0.00142	CcSEcCtD
Linagliptin—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000282	0.00142	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000274	0.00137	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000265	0.00133	CcSEcCtD
Linagliptin—Rash—Betamethasone—systemic lupus erythematosus	0.00026	0.00131	CcSEcCtD
Linagliptin—Rash—Dexamethasone—systemic lupus erythematosus	0.00026	0.00131	CcSEcCtD
Linagliptin—Dermatitis—Betamethasone—systemic lupus erythematosus	0.00026	0.00131	CcSEcCtD
Linagliptin—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.00026	0.00131	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000259	0.0013	CcSEcCtD
Linagliptin—Headache—Dexamethasone—systemic lupus erythematosus	0.000259	0.0013	CcSEcCtD
Linagliptin—Headache—Betamethasone—systemic lupus erythematosus	0.000259	0.0013	CcSEcCtD
Linagliptin—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000246	0.00124	CcSEcCtD
Linagliptin—Urticaria—Methotrexate—systemic lupus erythematosus	0.000239	0.0012	CcSEcCtD
Linagliptin—Rash—Prednisone—systemic lupus erythematosus	0.000227	0.00114	CcSEcCtD
Linagliptin—Dermatitis—Prednisone—systemic lupus erythematosus	0.000226	0.00114	CcSEcCtD
Linagliptin—Headache—Prednisone—systemic lupus erythematosus	0.000225	0.00113	CcSEcCtD
Linagliptin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000221	0.00111	CcSEcCtD
Linagliptin—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000206	0.00103	CcSEcCtD
Linagliptin—Rash—Methotrexate—systemic lupus erythematosus	0.000189	0.000951	CcSEcCtD
Linagliptin—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000189	0.000951	CcSEcCtD
Linagliptin—Headache—Methotrexate—systemic lupus erythematosus	0.000188	0.000945	CcSEcCtD
